Loading company details...
Latest Form 4 (Nov 4, 2026): David R. Epstein (Director): Sale of 370 shares, $27.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2026 | David R. Epstein | Sale | 370 | $27.5K |
| Nov 4, 2026 | Ryan Fukushima, CEO, Data | Grant/Award | 100,000 | n/a |
| Oct 29, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 10,428 | $702.4K |
| Sep 29, 2026 | Thomas Edward Schoenherr, CEO, Diagnostics | Sale | 10,281 | $873.9K |
| Sep 24, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 7,394 | $566.2K |
| Sep 19, 2026 | Eric P. Lefkofsky, CEO and Chairman | Sale | 52,558 | $4.23M |
| Sep 19, 2026 | Ryan M. Bartolucci, Chief Accounting Officer | Sale | 7,062 | $529.6K |
| Sep 19, 2026 | Andrew Polovin, EVP, Chief Legal Officer | Sale | 2,951 | $221.3K |
| Sep 19, 2026 | Ryan Fukushima, CEO, Data | Sale | 700 | $49.0K |
| Sep 1, 2026 | Nadja West | Sale | 3,000 | $207.0K |